Metabolism - Clinical and Experimental
Volume 59, Issue 4 , Pages 547-553, April 2010

Thyroid-stimulating hormone stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo

  • AnneMarie Gagnon

      Affiliations

    • Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6
    • Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada K1H 8M5
  • ,
  • Tayze T. Antunes

      Affiliations

    • Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6
    • Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada K1H 8M5
  • ,
  • Tapraya Ly

      Affiliations

    • Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6
    • Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada K1H 8M5
  • ,
  • Patama Pongsuwan

      Affiliations

    • Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6
    • Department of Medicine, University of Ottawa, Ottawa, ON, Canada K1H 8L6
  • ,
  • Claire Gavin

      Affiliations

    • Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6
    • Department of Medicine, University of Ottawa, Ottawa, ON, Canada K1H 8L6
  • ,
  • Heather A. Lochnan

      Affiliations

    • Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6
    • Department of Medicine, University of Ottawa, Ottawa, ON, Canada K1H 8L6
  • ,
  • Alexander Sorisky

      Affiliations

    • Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6
    • Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada K1H 8M5
    • Department of Medicine, University of Ottawa, Ottawa, ON, Canada K1H 8L6
    • Corresponding Author InformationCorresponding author. Ottawa Hospital Research Institute, Ottawa, ON, Canada K1H 8L6. Tel.: +1 613 737 8899x73320; fax: +1 613 737 8803.

Received 14 July 2009; accepted 25 August 2009. published online 21 October 2009.

Abstract 

Thyroid-stimulating hormone (TSH) stimulates adipocyte lipolysis, but signal transduction pathways activated by TSH for this response have not been directly studied. Using differentiated 3T3-L1 adipocytes as well as primary human adipocytes, we characterized the lipolytic action of TSH with dose-response and time-course studies, and compared it with isoproterenol. Thyroid-stimulating hormone stimulated phosphorylation of perilipin and hormone-sensitive lipase (HSL). Inhibition of protein kinase A with H89 blocked TSH-stimulated lipolysis as well as phosphorylation of perilipin and HSL. Thyroid-stimulating hormone stimulated lipolysis in vivo, as indicated by an elevation in serum free fatty acid (FFA) levels after recombinant human TSH administration to thyroidectomized patients (42% increase, n = 19, P < .05). For patients with a body mass index less than 30 kg/m2, the TSH-induced increase in serum FFA levels was 53% (n = 11, P < .05), whereas levels in patients with a body mass index of at least 30 kg/m2 (n = 8) did not change after TSH treatment. In summary, TSH stimulates lipolysis and phosphorylation of perilipin and HSL in a protein kinase A–dependent manner in differentiated adipocytes in culture and raises serum FFA levels in vivo.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The study was approved by the Ottawa Hospital Research Ethics Board (1995023-01H).

 Disclosure statement: HAL reports having received lecture fees from Genzyme Corporation. There are no disclosures from the other authors.

PII: S0026-0495(09)00363-1

doi:10.1016/j.metabol.2009.08.018

Metabolism - Clinical and Experimental
Volume 59, Issue 4 , Pages 547-553, April 2010